Intimations To Stock Exchange | RPG Life Sciences
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision, Values and Capabilities
    • Board of Directors
    • Management Team
    • Industry Awards and Recognition
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      • Environment, Health and Safety
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Rheumatology
    • Oncology
    • Urology
    • Anti-Diabetic
    • Respiratory
    • Gastroenterology
    • Cardiovascular
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Orthopedic
    • Neurology
    • Anti-Dengue
    • Dermatology
  • Life@RPGLS
    • Employee Connect
      Rewards and Recognition
      • Brave RPGLS Covid Warriors
      • Great Place To Work
      • Team Awards
      • Employee Awards
      Human Resources
      • Join Us
      • Company Events
      • Learning and Development
      CSR
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Corporate Presentations
      • Earnings Call
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • TDS on Dividend Communication
      • Forms related to Physical Shares
      • Newspaper Publications
      • Market Tracker
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • SCSR Committee
  • Media
    • Online News and Print Media
    • RPGLS @ Industry Platforms

INTIMATIONS TO STOCK EXCHANGE
  • Home
  • intimations to stock exchange

Sr. No. File Name (Click to Download)
1 Intimation about Closure of Trading Window March 31, 2023
2 Intimation of Issue of Duplicate Certificate March 28, 2023
3 Intimation of Issue of Duplicate Certificate, March 17,2023
4 Intimation of Issue of Duplicate Certificate March 14, 2023
5 Intimation of Issue of Duplicate Certificate February 16, 2023
6 Intimation of Issue of Duplicate Certificate January 13, 2023
7 Intimation for Loss of Certificate January 15,2023
8 Intimation for Loss of Certificate January 17,2023
9 Intimation for Loss of Certificate January 5,2023
10 Intimation for Loss of Certificate January 2,2023
11 Intimation for Loss of Certificate December 31,2022
12 Intimation about closing of Trading Window December 30, 2022
13 Intimation of Issue of Duplicate Certificate December 30,2022
14 Intimation of Issue of Duplicate Certificate December 16,2022
15 Intimation for Loss of Certificate December 7,2022
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Investors Information

Annual Conference Videos
  • June 16, 2021
  • Your browser does not support HTML5 video.
Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Earnings Call
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • TDS on dividend communication
  • Forms related to Physical Shares
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • SCSR Committee
Mandatory Disclosures
  • Code and Policies
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Offline PDF form
Drugs Safety – Adverse Event Reporting

Contact Us

  • Address:
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: +91 22 6660 6375 / 76 / 77

  • Fax: +91 22 2497 0127

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2018-19. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Sitemap